APA (7th ed.) Citation

Alhalabi, O. (2022). Utilizing gene expression profiling, phosphoproteomics and loss-of-function screens to enhance the therapeutic efficacy of dasatinib in glioblastoma.

Chicago Style (17th ed.) Citation

Alhalabi, Obada. Utilizing Gene Expression Profiling, Phosphoproteomics and Loss-of-function Screens to Enhance the Therapeutic Efficacy of Dasatinib in Glioblastoma. Heidelberg, 2022.

MLA (9th ed.) Citation

Alhalabi, Obada. Utilizing Gene Expression Profiling, Phosphoproteomics and Loss-of-function Screens to Enhance the Therapeutic Efficacy of Dasatinib in Glioblastoma. 2022.